Nuveen
SLDB icon

Nuveen’s Solid Biosciences SLDB Stock Holding History

Nuveen’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Sell
241,642
-158,650
-40% -$1.2M ﹤0.01% 2479
2026
Q1 		$2.88M Buy
400,292
+5,316
+1% +$34.2K ﹤0.01% 2124
2025
Q4 		$2.23M Hold
394,976
– – ﹤0.01% 2247
2025
Q3 		$2.44M Sell
394,976
-12,868
-3% -$75.2K ﹤0.01% 2227
2025
Q2 		$1.99M Buy
407,844
+364,265
+836% +$1.29M ﹤0.01% 2302
2025
Q1 		$161K Sell
43,579
-154,350
-78% -$661K ﹤0.01% 3157
2024
Q4 		$792K Sell
197,929
-4,735
-2% -$26K ﹤0.01% 2806
2024
Q3 		$1.41M Buy
202,664
+158,900
+363% +$1.29M ﹤0.01% 2598
2024
Q2 		$248K Buy
+43,764
New +$392K ﹤0.01% 3182
2022
Q2 		– Sell
-13,877
Closed -$266K – 3455
2022
Q1 		$266K Sell
13,877
-26,907
-66% -$475K ﹤0.01% 3145
2021
Q4 		$1.06M Sell
40,784
-10,341
-20% -$316K ﹤0.01% 2841
2021
Q3 		$2.15M Sell
51,125
-18,506
-27% -$786K ﹤0.01% 2641
2021
Q2 		$3.82M Buy
69,631
+4,014
+6% +$265K ﹤0.01% 2385
2021
Q1 		$5.44M Buy
65,617
+58,872
+873% +$6.51M ﹤0.01% 2132
2020
Q4 		$767K Buy
6,745
+1,241
+23% +$78.5K ﹤0.01% 2903
2020
Q3 		$908K Buy
5,504
+663
+14% +$25.4K ﹤0.01% 2729
2020
Q2 		$798K Buy
4,841
+412
+9% +$17.1K ﹤0.01% 2713
2020
Q1 		$159K Sell
4,429
-42
-0.9% -$2.08K ﹤0.01% 3025
2019
Q4 		$299K Sell
4,471
-1,028
-19% -$113K ﹤0.01% 3013
2019
Q3 		$853K Buy
5,499
+2,251
+69% +$255K ﹤0.01% 2758
2019
Q2 		$280K Buy
+3,248
New +$354K ﹤0.01% 3126

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nuveen's SLDB Position: Q2 2026 in Review

Nuveen reduced its Solid Biosciences (SLDB) stake by 40% in Q2 2026, selling an estimated $1.2M and leaving 241,642 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2479.

Nuveen first reported a position in SLDB in Q2 2019 and has held it in 21 quarters since. The position peaked at $5.44M in Q1 2021. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Nuveen held 241,642 shares of Solid Biosciences worth $2.41M as of Q2 2026.
  • Nuveen sold 158,650 Solid Biosciences shares in Q2 2026, an estimated $1.2M.
  • Solid Biosciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2479 holding.
  • Nuveen first reported a position in Solid Biosciences in Q2 2019 and has held it in 21 quarters since.
  • Nuveen's Solid Biosciences position peaked at $5.44M in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.